Vitiligo Following Dupilumab Therapy for Moderate-to-Severe Atopic Dermatitis: A Case Report with Insight into Type 1/Type 2 Immune Imbalance

Xiaopan Gong, Jing Chen, Ju Jiang, Qin Mei

Open source

DOI
10.2147/ccid.s643447
Published
2026-11
Container
Clinical, Cosmetic and Investigational Dermatology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ccid.s643447,
  title = {Vitiligo Following Dupilumab Therapy for Moderate-to-Severe Atopic Dermatitis: A Case Report with Insight into Type 1/Type 2 Immune Imbalance},
  author = {Xiaopan Gong and Jing Chen and Ju Jiang and Qin Mei},
  year = {2026},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  doi = {10.2147/ccid.s643447},
  url = {https://doi.org/10.2147/ccid.s643447}
}

RIS

TY  - JOUR
TI  - Vitiligo Following Dupilumab Therapy for Moderate-to-Severe Atopic Dermatitis: A Case Report with Insight into Type 1/Type 2 Immune Imbalance
AU  - Xiaopan Gong
AU  - Jing Chen
AU  - Ju Jiang
AU  - Qin Mei
PY  - 2026
JO  - Clinical, Cosmetic and Investigational Dermatology
DO  - 10.2147/ccid.s643447
UR  - https://doi.org/10.2147/ccid.s643447
ER  - 

APA

Gong, X., Chen, J., Jiang, J., & Mei, Q. (2026). Vitiligo Following Dupilumab Therapy for Moderate-to-Severe Atopic Dermatitis: A Case Report with Insight into Type 1/Type 2 Immune Imbalance. Clinical, Cosmetic and Investigational Dermatology. https://doi.org/10.2147/ccid.s643447

Source records